We screened 58 patients , of whom 45 were enrolled ( 22 assigned to daglutril then placebo , 23 to placebo then daglutril ; enrolment from May , 2005 , to December , 2006 ) and 42 ( 20 vs 22 ) were included in the primary analysis .